Sopharma Trading decided to appoint its former board chairman, Ognyan Donev, as new Chief Executive Officer replacing Dimitar Dimitrov. Donev is also CEO and indirectly the biggest shareholder of Sopharma Trading's majority owner - drug maker Sopharma. At the end of June, Sopharma held a 76.33% equity stake in Sopharma Trading, while Donev held directly a stake of under 5%.